Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving. (HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in ...

GLP-1 JABS may be able to ease symptoms of anxiety and depression by 40 per cent, a new study suggests. The blockbuster jabs ...

A new study has revealed another benefit of the diabetes medication turned weight loss drug Ozempic. Health experts now say it could also help those with alcohol-use disorder. A study published this ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

Among participants in the semaglutide treatment group, the likelihood of zero heavy drinking days increased significantly between weeks 1 through 4 and weeks 5 to 8. Glucagon-like peptide 1 receptor ...

Studies show promising results for semaglutide as a potential treatment for alcohol use disorder. Semaglutide, a GLP-1 drug, was initially used for type 2 diabetes treatment and weight loss. While ...

2/20/25 (LAPost.com) — New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption. The study, published in JAMA ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

Use of the glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and liraglutide is linked to a lower risk for alcohol use disorder (AUD)–related hospitalizations compared with traditional AUD ...

The study also reported a 42% lower risk of psychiatric hospitalizations and work absences during periods when patients were ...

A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol and cocaine. Reading time 2 minutes Semaglutide, the active ingredient in ...

Drugs such as semaglutide may be useful for mental health conditions associated with diabetes, authors say ...